Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up

Hemolytic anemia due to diphosphoglycerate mutase deficiency

MONDO:0009113

A rare, autosomal recessive, inherited disorder caused by mutation of the BPGM gene. It is characterized by hemolytic anemia and splenomegaly.

Also known as: diphosphoglycerate phosphatase deficiency, erythrocytosis, familial, 8, BPGM deficiency, DPGM deficiency, bisphosphoglycerate mutase deficiency, bisphosphoglyceromutase deficiency, diphosphoglycerate mutase deficiency of erythrocyte

64 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (618) Metabolic disease (215) Anemia (203) Hereditary disease (172) Hematologic disorder (160) Inborn errors of metabolism (42) Hemolytic anemia (17) Human disease (14) Familial hemolytic anemia (3) Disease of genetic or genomic mechanism (2)
Trials to join now! 32 Not yet recruiting 5 Not yet finished but already full! 8 Completed 18 Terminated 1
Sort by
  • Can extra care after transplant help older patients live better?

    Disease control Terminated

    This study tested two extra care programs—supportive palliative care and clinical management of other health issues—for older or frail patients who had a donor stem cell transplant. The goal was to see if these programs could improve quality of life and survival compared to stand…

    Phase: PHASE2, PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control

    Last updated Jun 27, 2026 08:10 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space